Yoon Jong Choi

2.9k total citations · 1 hit paper
19 papers, 1.9k citations indexed

About

Yoon Jong Choi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoon Jong Choi has authored 19 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoon Jong Choi's work include Cancer-related Molecular Pathways (10 papers), Advanced Breast Cancer Therapies (7 papers) and Epigenetics and DNA Methylation (5 papers). Yoon Jong Choi is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Advanced Breast Cancer Therapies (7 papers) and Epigenetics and DNA Methylation (5 papers). Yoon Jong Choi collaborates with scholars based in United States and Canada. Yoon Jong Choi's co-authors include Piotr Siciński, Per Hydbring, Anil Narasimha, Gary S. Shapiro, Steven F. Dowdy, Manuel Kaulich, Lars Anders, Nan Rosemary Ke, Stephen P. Gygi and Huili Zhai and has published in prestigious journals such as Nature, Cell and Blood.

In The Last Decade

Yoon Jong Choi

18 papers receiving 1.9k citations

Hit Papers

A Systematic Screen for CDK4/6 Substrates Links FOXM1 Pho... 2011 2026 2016 2021 2011 100 200 300 400

Peers

Yoon Jong Choi
Xiangpeng Dai United States
Stefanie S. Schalm United States
Teresa Klinowska United Kingdom
Lori S. Hart United States
Lars Anders United States
Kiran Mahajan United States
Jung-Sik Kim United States
Yoon Jong Choi
Citations per year, relative to Yoon Jong Choi Yoon Jong Choi (= 1×) peers Alberto Martín

Countries citing papers authored by Yoon Jong Choi

Since Specialization
Citations

This map shows the geographic impact of Yoon Jong Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon Jong Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon Jong Choi more than expected).

Fields of papers citing papers by Yoon Jong Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon Jong Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon Jong Choi. The network helps show where Yoon Jong Choi may publish in the future.

Co-authorship network of co-authors of Yoon Jong Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon Jong Choi. A scholar is included among the top collaborators of Yoon Jong Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon Jong Choi. Yoon Jong Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
House, Nealia C., Maxine Chen, Liang Yuan, et al.. (2025). Profiling the Activity of the Potent and Highly Selective CDK2 Inhibitor BLU-222 Reveals Determinants of Response in CCNE1 -Aberrant Ovarian and Endometrial Tumors. Cancer Research. 85(7). 1297–1309. 6 indexed citations
2.
House, Nealia C., et al.. (2023). CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination. NAR Cancer. 5(3). zcad039–zcad039. 15 indexed citations
4.
House, Nealia C., Jian Guo, Ruduan Wang, et al.. (2022). Abstract 2306: BLU-222, an investigational, potent, and selective CDK2 inhibitor, demonstrated robust antitumor activity in CCNE1-amplified ovarian cancer models. Cancer Research. 82(12_Supplement). 2306–2306. 8 indexed citations
6.
Hu, Shanhu, Nan Rosemary Ke, Yixuan Ren, et al.. (2017). Abstract 1151: SY-1365, a potent and selective CDK7 inhibitor, exhibits promising anti-tumor activity in multiple preclinical models of aggressive solid tumors. Cancer Research. 77(13_Supplement). 1151–1151. 3 indexed citations
7.
Hu, Shanhu, Nan Rosemary Ke, Yixuan Ren, et al.. (2016). Abstract 4820: Selective CDK7 inhibitors suppress super enhancer-genes, induce massive apoptosis in acute myeloid leukemia and demonstrate durable in vivo efficacy. Cancer Research. 76(14_Supplement). 4820–4820. 1 indexed citations
8.
Ren, Yixuan, Victoria Brown, Shanhu Hu, et al.. (2015). Targeting Transcriptional Dependency in Acute Myeloid Leukemia (AML) with a Covalent Inhibitor of Transcriptional Kinase CDK7. Blood. 126(23). 1354–1354. 1 indexed citations
9.
Orlando, David A., Mei Wei Chen, Victoria E. Brown, et al.. (2014). Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome. Cell Reports. 9(3). 1163–1170. 309 indexed citations
10.
Lee, Yoon‐Jin, John E. Dominy, Yoon Jong Choi, et al.. (2014). Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression. Nature. 510(7506). 547–551. 184 indexed citations
11.
Choi, Yoon Jong, Borja Sáez, Lars Anders, et al.. (2014). D-Cyclins Repress Apoptosis in Hematopoietic Cells by Controlling Death Receptor Fas and Its Ligand FasL. Developmental Cell. 30(3). 255–267. 23 indexed citations
12.
Narasimha, Anil, Manuel Kaulich, Gary S. Shapiro, et al.. (2014). Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. eLife. 3. 332 indexed citations
13.
Bailey, Shannon T., Penelope Miron, Yoon Jong Choi, et al.. (2013). NF-κB Activation-Induced Anti-apoptosis Renders HER2-Positive Cells Drug Resistant and Accelerates Tumor Growth. Molecular Cancer Research. 12(3). 408–420. 42 indexed citations
14.
Choi, Yoon Jong, Xiaoyu Li, Per Hydbring, et al.. (2012). The Requirement for Cyclin D Function in Tumor Maintenance. Cancer Cell. 22(4). 438–451. 258 indexed citations
15.
Kreslavsky, Taras, Michael Gleimer, Masaki Miyazaki, et al.. (2012). β-Selection-Induced Proliferation Is Required for αβ T Cell Differentiation. Immunity. 37(5). 840–853. 74 indexed citations
16.
Anders, Lars, Nan Rosemary Ke, Per Hydbring, et al.. (2011). A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells. Cancer Cell. 20(5). 620–634. 431 indexed citations breakdown →
17.
Kalaszczyńska, Ilona, Yan Geng, Tadafumi Iino, et al.. (2009). Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells. Cell. 138(2). 352–365. 157 indexed citations
18.
Das, Gaurav, Yoon Jong Choi, Piotr Siciński, & Edward M. Levine. (2009). Cyclin D1 fine-tunes the neurogenic output of embryonic retinal progenitor cells. Neural Development. 4(1). 15–15. 56 indexed citations
19.
Park, Dong Hun, Hyun‐Soo Kim, Moon Young Kim, et al.. (2002). Effectiveness of Walking-exercise on Bowel Preparation for Colonoscopy. Clinical Endoscopy. 25(2). 76–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026